Cochrane Clinical Answers - Access Denied - Does evidence from randomized controlled trials support the use of high-concentration (8%) topical capsaicin over placebo in adults with chronic neuropathic pain?

Question:Does evidence from randomized controlled trials support the use of high-concentration (8%) topical capsaicin over placebo in adults with chronic neuropathic pain?

THIS CLINICAL ANSWER IS UPDATED

EXCERPT of full Clinical Answer

This Cochrane Clinical Answer evaluates high-concentration topical capsaicin versus placebo in people with chronic neuropathic pain.

Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.

Are you a COCHRANE CLINICAL ANSWERS subscriber?

SUBSCRIBE NOW to read the full answer

A subscription to THE COCHRANE LIBRARY is required.